Bryant Furlow

Contributing Writer https://www.oncologynurseadvisor.com

Bryant Furlow is a contract medical journalist for the Haymarket Medical Network. He holds a BS in biology (summa cum laude) from the University of New Mexico. He covers radiation oncology, immunotherapy, tumor biology, clinical research and health care policy. Prior to joining Haymarket in 2010, Bryant was a newspaper reporter in New Mexico, where he won awards for public health and investigative journalism. He also reports for The Lancet Oncology news desk.

All articles by Bryant Furlow

Proton therapy for cancer: The evidence isn’t yet there

The proton therapy debate centers on the high cost of facilities and the equivocal evidence for superior tumor control and patient survival.

Bryant Furlow

July 15, 2010

Lymphedema: Diagnosis, prevention, and management

Lymphedema diminishes function, causes chronic pain, and may make working impossible. Prevention is most effective.

Bryant Furlow

July 14, 2010

Reducing occupational exposures to chemotherapy drugs: The emergence of closed-system drug transfer devices (CSTDs)

CSTDs will promote safer administration of chemotherapy drugs.

Bryant Furlow

June 15, 2010

Evolving roles for lung cancer radiation therapy

Recent advances in the timing and targeting of radiation therapy promise to help minimize the collateral damage radiotherapy inflicts on healthy tissues — trends that were on display at the second European Lung Cancer Conference.

Bryant Furlow

June 15, 2010